Herpes Simplex Virus 2 News and Research

RSS
Herpes Simplex Virus-2 is a sexually transmitted viral infection, which often produces painful sores, usually in the genital area. Once infected, an individual may carry the virus and be subject to recurrent bouts of infection. Some estimate that as many as 20 percent of the adult population in the United States has been exposed to the virus.
Researchers reveal how stress conditions favor lytic reactivation of herpesviruses

Researchers reveal how stress conditions favor lytic reactivation of herpesviruses

High school wrestlers have highest number of skin infections

High school wrestlers have highest number of skin infections

Study shows several Envigo rat models susceptible to genital HSV-2 infection

Study shows several Envigo rat models susceptible to genital HSV-2 infection

Rutgers Cancer Institute scientist leads phase III trial of FDA-approved viral melanoma therapy

Rutgers Cancer Institute scientist leads phase III trial of FDA-approved viral melanoma therapy

Over 3.7 billion people under 50 have genital HSV-1 infection, shows WHO report

Over 3.7 billion people under 50 have genital HSV-1 infection, shows WHO report

FDA permits marketing of first CSF nucleic acid-based test for detection of multiple pathogens

FDA permits marketing of first CSF nucleic acid-based test for detection of multiple pathogens

Quest Diagnostics receives FDA 510(k) clearance for Simplexa HSV 1 & 2 Direct molecular test

Quest Diagnostics receives FDA 510(k) clearance for Simplexa HSV 1 & 2 Direct molecular test

Blavatnik Biomedical Accelerator funds advanced biomedical research projects

Blavatnik Biomedical Accelerator funds advanced biomedical research projects

Researchers capture images of immune cell interactions rallying to destroy herpes simplex virus

Researchers capture images of immune cell interactions rallying to destroy herpes simplex virus

Reducing amyloid fibril levels in semen may help reduce transmission of HIV

Reducing amyloid fibril levels in semen may help reduce transmission of HIV

NanoViricides speeds up HerpeCide drug development program

NanoViricides speeds up HerpeCide drug development program

Anna Nele Meckler and Armelle Corpet to receive SNSF's 2015 Marie Heim-Vögtlin Prize

Anna Nele Meckler and Armelle Corpet to receive SNSF's 2015 Marie Heim-Vögtlin Prize

Roche announces FDA 510(k) clearance for cobas HSV 1 and 2 Test

Roche announces FDA 510(k) clearance for cobas HSV 1 and 2 Test

Roche announces FDA clearance for cobas Cdiff Test to detect C. difficile in stool specimens

Roche announces FDA clearance for cobas Cdiff Test to detect C. difficile in stool specimens

NanoViricides' anti-viral drug candidates show promise in lethal animal model of dermal herpes infection

NanoViricides' anti-viral drug candidates show promise in lethal animal model of dermal herpes infection

Trio of Andor EMCCD cameras chosen to unravel the inner structure of Herpes simplex virus

Trio of Andor EMCCD cameras chosen to unravel the inner structure of Herpes simplex virus

St. Luke’s Cancer Center offers new Phase II oncolytic viral therapy clinical trial for advanced melanoma

St. Luke’s Cancer Center offers new Phase II oncolytic viral therapy clinical trial for advanced melanoma

Rare genetic mutation explains why flu can kill in rare cases

Rare genetic mutation explains why flu can kill in rare cases

Personalized gene therapy to fight against cancer

Personalized gene therapy to fight against cancer

Common herpes drug Valacyclovir decreases HIV-1 levels

Common herpes drug Valacyclovir decreases HIV-1 levels